Trial record 1 of 1 for:    Phase I/II Administration of CMV-specific cytotoxic T cells in patients with Glioblastoma multiforme
Previous Study | Return to List | Next Study

Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme (COGLI)

This study has been terminated.
(poor accrual)
Sponsor:
Collaborators:
Texas Children's Hospital
Center for Cell and Gene Therapy, Baylor College of Medicine
The Methodist Hospital System
Information provided by (Responsible Party):
Nabil Ahmed, Baylor College of Medicine
ClinicalTrials.gov Identifier:
NCT01205334
First received: September 17, 2010
Last updated: August 17, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: August 17, 2013